Immortal time bias and infliximab-related mortality and malignancy incidence
- PMID: 20207649
- DOI: 10.1136/gut.2009.186445
Immortal time bias and infliximab-related mortality and malignancy incidence
Comment on
-
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study.Gut. 2009 Apr;58(4):501-8. doi: 10.1136/gut.2008.163642. Epub 2008 Oct 2. Gut. 2009. PMID: 18832524
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources